International Vaccine Institute and Bharat Biotech launch Phase II and III trials for chikungunya vaccine

Source: Indian Express What is the news? A multi-country Phase II / III clinical trial of a vaccine led by the International Vaccine Institute (IVI) in partnership with Bharat Biotech International Ltd (BBIL) has begun in Costa Rica. Read more: World may soon get a vaccine against Chikungunya What is Chikungunya? It is a viral disease transmitted… Continue reading International Vaccine Institute and Bharat Biotech launch Phase II and III trials for chikungunya vaccine